Filing Details
- Accession Number:
- 0001209191-10-053072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-04 10:31:54
- Reporting Period:
- 2010-11-02
- Filing Date:
- 2010-11-04
- Accepted Time:
- 2010-11-04 10:31:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1458451 | Scott Seiwert | 3280 Bayshore Blvd. Brisbane CA 94005 | Svp, Rsearch & Technical Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-11-02 | 8,308 | $13.27 | 51,974 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price per share for the entire number of shares purchased. The purchase prices range from $13.2599 to $13.27 per share. Full information on the numbers of shares purchased at each purchase price is available upon request.